Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure - Concepedia

Concepedia

Publication | Open Access

Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure

DOI Full Paper Access

89

Citations

14

References

2000

Year

Gilles Freyer, P Rougier, R. Bugat, J‐P Droz, Marion Marty, Harry Bleiberg, D. Mignard, Lucile Awad, Patrice Herait, Stéphane Culine,

British Journal of Cancer

References

	Year	Citations

Page 1